buPropion Hydrochloride XL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72516-035 -
Package NDC
72516-035-03 -
Package NDC
72516-035-09 -
Package NDC
72516-035-50 -
Application number
ANDA211200 -
SPL ID
47afeb95-a677-8969-e063-6294a90a7b2d -
SPL set ID
004d8121-59d4-46c4-acb8-b2dd097bf556 -
UNII
ZG7E5POY8O -
RxCUI
993541 -
RxCUI
993557
What the source publishes
- Labeler
- Oryza pharmaceuticals Inc.
- Active ingredients
- bupropion hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "buPropion Hydrochloride XL",
"splId": "47afeb95-a677-8969-e063-6294a90a7b2d",
"labels": [
{
"setId": "004d8121-59d4-46c4-acb8-b2dd097bf556",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=004d8121-59d4-46c4-acb8-b2dd097bf556",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=004d8121-59d4-46c4-acb8-b2dd097bf556"
}
],
"routes": [
"ORAL"
],
"labeler": "Oryza pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-03)",
"package_ndc": "72516-035-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20201001"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-09)",
"package_ndc": "72516-035-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20201001"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-035-50)",
"package_ndc": "72516-035-50",
"identifierStatus": "well-formed",
"marketing_start_date": "20201001"
}
],
"productId": "72516-035_47afeb95-a677-8969-e063-6294a90a7b2d",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "72516-035",
"deaSchedule": null,
"genericName": "bupropion hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BUPROPION HYDROCHLORIDE",
"strength": "150 mg/1"
}
],
"applicationNumber": "ANDA211200",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20201001",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0372516036096",
"0372516036508",
"0372516035037",
"0372516035099",
"0372516035501",
"0372516036034"
],
"unii": [
"ZG7E5POY8O"
],
"rxcui": [
"993541",
"993557"
],
"spl_set_id": [
"004d8121-59d4-46c4-acb8-b2dd097bf556"
],
"manufacturer_name": [
"Oryza pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72516-035_47afeb95-a677-8969-e063-6294a90a7b2d"